FdaApplication
BLA 125504
Identifiers
- fda_app_no: BLA125504
Properties
| Property | Value |
|---|---|
| applicant_name | Novartis Pharmaceuticals Corporation |
| application_type | BLA |
| approval_date | 2015-01-21 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| COSENTYX | SECUKINUMAB | 150MG/ML | Injection |
| COSENTYX | — | 150MG | For Injection |
| COSENTYX | — | 300MG/2ML | Injection |
| COSENTYX | — | 150MG/ML | Injection |
| COSENTYX | — | 75MG/0.5ML | Injection |
| COSENTYX | — | 300MG/2ML | Injection |
6 products